Weight loss moderately greater with 4:3 IMF versus daily calorie restriction in adults with overweight, obesity
MONDAY, March 31, 2025 (HealthDay News) — An intermittent fasting (IMF) intervention yields modestly greater weight loss than daily caloric restriction (DCR) among adults with overweight or obesity, according to a study published online April 1 in the Annals of Internal Medicine.
Victoria A. Catenacci, M.D., from the University of Colorado Anschutz Medical Campus in Aurora, and colleagues compared the effects of 4:3 IMF versus DCR on changes in weight at 12 months with comprehensive behavioral support in a randomized clinical trial involving adults aged 18 to 60 years with a body mass index of 27 to 46 kg/m2. The IMF group was instructed to restrict energy intake by 80 percent on three nonconsecutive days per week, with no restriction on the other four days (4:3 IMF). The DCR group was instructed to match the weekly energy deficit by reducing daily energy intake by 34 percent. Both groups also received a high-intensity comprehensive behavioral weight loss program.
The study included 165 participants: 84 4:3 IMF and 81 DCR; 125 individuals completed the trial. The researchers found that at 12 months, 4:3 IMF showed greater reductions in weight than DCR in an intention-to-treat analysis (mean difference, 2.89 kg).
“4:3 IMF should be considered within the range of evidence-based dietary weight loss approaches,” the authors write.
Abstract/Full Text (subscription or payment may be required)
Calorie Restriction and Mediterranean-Style Diet Yield Similar Weight Loss
Strength Training May Cut GDM Risk in Pregnant Women With Overweight, Obesity
Most Metabolic and Bariatric Surgery Candidates Meet Criteria for Clinical Obesity
Central Adiposity Reclassifies Cardiovascular Risk Across BMI Spectrum
2011 to 2021 Saw Heart Failure-Related Hospitalization Rise in CKD
Machine Learning Model IDs Heart Failure With Reduced Ejection Fraction Using Routine Lab Indicators
Reinitiating Obesity Meds After Bariatric Surgery Tied to Greater One-Year Weight Loss in Youths
High-Dose Omega-3 Linked to A-Fib Risk in Patients With High CVD Risk